CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
Epstein Barr virus (EBV) is one of the most ubiquitous human pathogens in the world, persistently infecting more than 90% of the adult human population. It drives some of the strongest human CD8+ T cell responses, which can be observed during symptomatic primary infection known as infectious mononuc...
Main Authors: | Bithi Chatterjee, Yun Deng, Angelika Holler, Nicolas Nunez, Tarik Azzi, Liliana Danusia Vanoaica, Anne Müller, Hana Zdimerova, Olga Antsiferova, Andrea Zbinden, Riccarda Capaul, Johannes H Dreyer, David Nadal, Burkhard Becher, Mark D Robinson, Hans Stauss, Christian Münz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-05-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1007748 |
Similar Items
-
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
by: Anita Murer, et al.
Published: (2019-01-01) -
Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo”
by: Anita Murer, et al.
Published: (2019-07-01) -
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
by: Obinna Chijioke, et al.
Published: (2015-08-01) -
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
by: Obinna Chijioke, et al.
Published: (2013-12-01) -
Dendritic cells during Epstein Barr virus infection
by: Christian eMunz
Published: (2014-06-01)